Fmr LLC Buys 212 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Fmr LLC increased its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 12.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,905 shares of the company’s stock after buying an additional 212 shares during the quarter. Fmr LLC’s holdings in VanEck Pharmaceutical ETF were worth $181,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of PPH. International Assets Investment Management LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $86,000. Envestnet Portfolio Solutions Inc. acquired a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth approximately $211,000. Edge Financial Advisors LLC bought a new stake in VanEck Pharmaceutical ETF during the 3rd quarter worth approximately $263,000. Harbour Investments Inc. increased its holdings in VanEck Pharmaceutical ETF by 16.6% during the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock valued at $325,000 after purchasing an additional 488 shares in the last quarter. Finally, Assetmark Inc. raised its position in VanEck Pharmaceutical ETF by 5.8% in the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock valued at $617,000 after purchasing an additional 354 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $86.54 on Friday. VanEck Pharmaceutical ETF has a 52 week low of $79.95 and a 52 week high of $99.51. The stock has a market capitalization of $639.53 million, a PE ratio of 21.04 and a beta of 0.72. The stock’s fifty day moving average is $90.24 and its 200-day moving average is $92.87.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.